UNSPSC 51283959: Benzylsulfamide

This classification denotes a topical anti-infective agent with the molecular formula C13H14N2O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AI9WDT80FQ, chemically known as sulfanilamide, n(sup 4)-benzyl- but more generally known as benzylsulfamide, which bears US NIH Compound Identifier 66909. European Medicines Agency schedules Benzylsulfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05773MIG.

The term BENZYLSULFAMIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 16, No. 3 1962, List 4). BENZYLSULFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(NCC1CCCCC1)C1CCC(N)CC1.

UNSPSC 51283959 Benzylsulfamide is a Commodity code that, based on recent state and local opportunities, encompasses pharmaceutical products and related supplies procured through cooperative purchasing vehicles and competitive bidding. State and local health departments and county health authorities are the primary issuing bodies soliciting under this code, typically through piggyback contracts leveraging multi-state cooperative purchasing consortia or direct competitive invitation-for-bid processes. The scope of work includes acquisition of pharmaceuticals and medical countermeasures for public health use, including antibiotics, opioid antagonists, and drug deactivation systems. These purchases support community health initiatives and emergency preparedness within state and county health systems.

Recent activity shows Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets under IFB 26482DPHPREPDB53392, with an initial 12-month term and renewal options through year 3. Seminole County, Florida issued an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida. The Illinois and Florida opportunities reflect the geographic distribution of recent activity. Both procurements required vendors to submit pricing on an electronically posted platform with fixed-fee award structures, and neither applied explicit set-asides or domestic-product preferences in their evaluation criteria.